OPKOPKO Health, Inc.

$1.38-4.8% 1Y

$1.38

$1.1052 weeks$1.73

OPK in its own filings

OPK's filing record carries 4 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.

601

Events found in the filings · across 3,000 filings · the record starts in 1997

Hard flags: 4
Hard flags
Most recent filing: Oct 2, 2026
Most recent filing · Form 8-K
Record starts: May 2, 1997
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Oct 28, 2026
Restatement admitted (non-reliance)historical: 2010-11-09
Change in certifying accountant3 occurrences: 2007-04-13
Late periodic report5 occurrences: 2024-03-01
Delisting notice / listing-rule failure4 occurrences: 2012-10-19
Security removed from listing or deregistered2 occurrences · usually a matured note or preferred class, not the common shares: 2016-06-23
SEC comment-letter activity37 occurrences: 2018-12-26

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Oct 2, 2026On October 1, 2026, OPKO Health, Inc. (the “Company”) determined that its 3.75% Convertible Senior Notes due 2029 (the “Notes”), of which approximately $121 million is outstanding, are convertible by holders of such Notes through December 31, 2026.Other event · Form 8-K
Aug 14, 2026On August 13, 2026, OPKO Health, Inc. (the “Company”) entered into an amendment (the “Amendment”) to the initial Note Purchase Agreement dated July 17, 2024 (the “Original Agreement”; and as amended by the Amendment, the “Amended Agreement”) with certain purchasers party thereto from time to time, its wholly-owned …Material agreement entered · Form 8-K
Jul 27, 2026OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results.Earnings release · press release
Apr 28, 2026OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results.Earnings release · press release
Mar 19, 2026On March 18, 2026, the Board of Directors of OPKO Health, Inc. (the “Company”), appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company’s 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation.Director or officer change · Form 8-K
Feb 26, 2026OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results.Earnings release · press release
Oct 29, 2025OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results.Earnings release · press release